SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 9.240-5.3%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Doc Bones11/7/2006 8:14:02 AM
Read Replies (1) of 557
 
7:34AM Targeted Genetics and Biogen Idec restructure debt (TGEN) 2.15 :

Co announces that it has entered into a newly amended agreement with Biogen Idec (BIIB) to restructure repayment of $8.15 mln of debt. Under the terms of this amendment, BIIB has agreed to convert $5.65 mln of debt into 1 mln shares of TGEN common stock. TGEn will pay $500,000 of the remaining debt immediately and the remaining $2 mln in debt will be paid according to a new repayment schedule. As a result of the restructured relationship, BIIB's equity holdings in TTGEN will increase to 19.9% of the total outstanding common stock.

finance.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext